The Board of Medicine, a nonprofit organization dedicated to establishing evidence-based clinical guidelines for emerging medical practices, has launched a new membership program. This initiative grants healthcare practitioners and the general public access to advanced research, educational resources, and professional training focused on innovative areas such as psychedelic-assisted therapy, wearable health technology, plant medicine, somatic therapy, and supplement optimization.
Founded in 2019, The Board of Medicine convenes world-renowned experts to address topics that conventional medical institutions may not yet fully explore. The membership is presented as a tiered system, ranging from $50 to $1,500 annually. Member benefits include newsletters, clinical guidelines, webinars, live events, expert consultations, discounts on third-party testing and product certifications, and opportunities to help shape emerging standards of care.
Image Credit: The Board of Medicine
What's Driving This Trend
- Democratized Medical Knowledge
- A widening availability of specialist-guided research and guidelines creates potential to upend traditional gatekeepers of clinical information by enabling new public-facing channels for validated medical content.
- Tiered Clinical Memberships
- This paid, layered-access structure introduces business models that can redefine how practitioners and consumers pay for and access continuing education and specialty resources.
- Integration of Emerging Therapies
- Broader institutional attention to modalities like psychedelic-assisted therapy and plant medicine signals opportunities to formalize novel care pathways and standardize previously fragmented treatment options.
Who This Affects Most
- Healthcare Education
- Expanded membership curricula and expert-led webinars create avenues for new credentialing, microlearning products, and subscription-based professional development offerings.
- Digital Health Platforms
- Platforms that aggregate guidelines, teleconsultations, and certified resources have room to disrupt incumbents by bundling evidence-based content with consumer-facing tools and practitioner networks.
- Certification and Testing Labs
- Demand for third-party testing, product certifications, and standardized assessments opens space for specialized labs and accreditation services that validate emerging therapeutic products and protocols.
